Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Pancreatic safety of incretin-based drugs–FDA and EMA assessment

Open access
Egan, Amy G., Blind, Eberhard, Dunder, Kristina, de Graeff, Pieter A., Hummer, B. Timothy, Bourcier, Todd, Rosebraugh, Curtis · 2014 · New England Journal of Medicine

Abstract

A guide to clinical management and public health response for hand, foot and mouth disease (HFMD).

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmp1314078

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 4 references

Cited by

See all 509

Metadata

Authors
Egan, A. G., Blind, E., Dunder, K., de Graeff, P. A., Hummer, B. T., Bourcier, T., & Rosebraugh, C.
Affiliations
  • European Medicines Agency (NL)
  • Medical Products Agency (SE)
  • United States Food and Drug Administration (US)
Venue
New England Journal of Medicine
Published
2014-02-27
Volume
370
Issue
9
Pages
794-797
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1970905724
Cited by
498
References
4
Citations by year
2026: 11 · 2025: 27 · 2024: 21 · 2023: 18 · 2022: 23 · 2021: 26 · 2020: 26 · 2019: 35 · 2018: 45 · 2017: 53 · 2016: 66 · 2015: 81 · 2014: 65
FWCI
71.04
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
Keywords
incretin-based drugs, drug safety assessment, FDA regulatory review, drug approval
MeSH terms
Animals, Diabetes Mellitus, Type 2, Drug Evaluation, Preclinical, European Union, Humans, Hypoglycemic Agents, Pancreatic Neoplasms, Pancreatitis, United States, United States Food and Drug Administration, Drug Approval, Mice, Rats, Incretins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pancreatic safety of incretin-based drugs–FDA and EMA assessment. https://app.cochat.ai/papers/10.1056/nejmp1314078
The paper
Egan, A. G., Blind, E., Dunder, K., de Graeff, P. A., Hummer, B. T., Bourcier, T., & Rosebraugh, C. (2014). Pancreatic safety of incretin-based drugs–FDA and EMA assessment. New England Journal of Medicine. https://doi.org/10.1056/nejmp1314078

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.